Service d'immunologie et d'allergie

Equipe principale
Publications | Mémoires et thèses

La recherche avancée est accessible via Serval

Les publications peuvent être gérées en accédant à Serval via MyUnil


1804 publications

... | 2021 | 2020 | 2019 | 2018 | ...
2021
 
Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study.
Meier A.L., Bodmer N.S., Wirth C., Bachmann L.M., Ribi C., Pröbstel A.K., Waeber D., Jelcic I., Steiner U.C., Swiss SLE Cohort Study (SSCS), 2021/09. Lupus, 30 (10) pp. 1565-1576. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_28293ADE1035]
 
Reactivation of IgA vasculitis after COVID-19 vaccination.
Obeid M., Fenwick C., Pantaleo G., 2021/09. The Lancet. Rheumatology, 3 (9) pp. e617. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1D8F6DD0B85B]
 
Targeting SARS-CoV-2 receptor-binding domain to cells expressing CD40 improves protection to infection in convalescent macaques.
Marlin R., Godot V., Cardinaud S., Galhaut M., Coleon S., Zurawski S., Dereuddre-Bosquet N., Cavarelli M., Gallouët A.S., Maisonnasse P. et al., 2021/09/01. Nature communications, 12 (1) p. 5215. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90B177569A3B]
 
Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus.
Kiener S., Ribi C., Keller I., Chizzolini C., Trendelenburg M., Huynh-Do U., von Kempis J., On Behalf Of Swiss Sle Cohort Study Sscs, Leeb T., 2021/08/19. Genes, 12 (8) p. 1268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_118F317D2FDE]
 
Immunological Assessment of Pediatric Multisystem Inflammatory Syndrome Related to Coronavirus Disease 2019.
Grazioli S., Tavaglione F., Torriani G., Wagner N., Rohr M., L'Huillier A.G., Leclercq C., Perrin A., Bordessoule A., Beghetti M. et al., 2021/08/14. Journal of the Pediatric Infectious Diseases Society, 10 (6) pp. 706-713. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_808A82307D7F]
Glycolysis downregulation is a hallmark of HIV-1 latency and sensitizes infected cells to oxidative stress.
Shytaj I.L., Procopio F.A., Tarek M., Carlon-Andres I., Tang H.Y., Goldman A.R., Munshi M., Kumar Pal V., Forcato M., Sreeram S. et al., 2021/08/09. EMBO molecular medicine, 13 (8) pp. e13901. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B314A864B89C]
The cytokines HGF and CXCL13 predict the severity and the mortality in COVID-19 patients.
Perreau M., Suffiotti M., Marques-Vidal P., Wiedemann A., Levy Y., Laouénan C., Ghosn J., Fenwick C., Comte D., Roger T. et al., 2021/08/09. Nature communications, 12 (1) p. 4888. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D985FAB1BA6B]
A high-throughput cell- and virus-free assay shows reduced neutralization of SARS-CoV-2 variants by COVID-19 convalescent plasma.
Fenwick C., Turelli P., Pellaton C., Farina A., Campos J., Raclot C., Pojer F., Cagno V., Nusslé S.G., D'Acremont V. et al., 2021/08/04. Science translational medicine, 13 (605) pp. eabi8452. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_DB7C1B80A401]
Eculizumab as a New Treatment for Severe Acute Post-infectious Glomerulonephritis: Two Case Reports.
Chehade H., Guzzo G., Cachat F., Rotman S., Teta D., Pantaleo G., Sadallah S., Sharma A., Rosales I.A., Tolkoff-Rubin N. et al., 2021/07/31. Frontiers in medicine, 8 p. 663258. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_78558A2B0C1B]
 
CD177, a specific marker of neutrophil activation, is associated with coronavirus disease 2019 severity and death.
Lévy Y., Wiedemann A., Hejblum B.P., Durand M., Lefebvre C., Surénaud M., Lacabaratz C., Perreau M., Foucat E., Déchenaud M. et al., 2021/07/23. iScience, 24 (7) p. 102711. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_909F730EC11C]
Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report.
Guzzo G., Kissling S., Pantaleo G., Pascual M., Sadallah S., Teta D., 2021/07/06. BMC nephrology, 22 (1) p. 252. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5BD58C2F1EDF]
SARS-CoV-2 seroprevalence in healthcare workers of a Swiss tertiary care centre at the end of the first wave: a cross-sectional study.
Meylan S., Dafni U., Lamoth F., Tsourti Z., Lobritz M.A., Regina J., Bressin P., Senn L., Grandbastien B., Andre C. et al., 2021/07/05. BMJ open, 11 (7) pp. e049232. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_471F833F0211]
The burden of systemic sclerosis in Switzerland - the Swiss systemic sclerosis EUSTAR cohort.
Hernández J., Jordan S., Dobrota R., Iudici M., Hasler P., Ribi C., Villiger P., Vlachoyiannopoulos P., Vacca A., Garzanova L. et al., 2021/07/05. Swiss medical weekly, 151 pp. w20528. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_13A29E01262E]
Encephalopathies Associated With Severe COVID-19 Present Neurovascular Unit Alterations Without Evidence for Strong Neuroinflammation.
Bernard-Valnet R., Perriot S., Canales M., Pizzarotti B., Caranzano L., Castro-Jiménez M., Epiney J.B., Vijiala S., Salvioni-Chiabotti P., Anichini A. et al., 2021/07. Neurology, 8 (5) pp. e1029. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2403F6DD5AAC]
HIV persistence in lymph nodes.
Banga R., Munoz O., Perreau M., 2021/07/01. Current opinion in HIV and AIDS, 16 (4) pp. 209-214. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5241DE0E66BD]
 
Prevalence of SARS-CoV-2 in Household Members and Other Close Contacts of COVID-19 Cases: A Serologic Study in Canton of Vaud, Switzerland.
Dupraz J., Butty A., Duperrex O., Estoppey S., Faivre V., Thabard J., Zuppinger C., Greub G., Pantaleo G., Pasquier J. et al., 2021/07. Open forum infectious diseases, 8 (7) pp. ofab149. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FDA752E9104B]
 
Cervicovaginal Tissue Residence Confers a Distinct Differentiation Program upon Memory CD8 T Cells.
Davé V.A., Cardozo-Ojeda E.F., Mair F., Erickson J., Woodward-Davis A.S., Koehne A., Soerens A., Czartoski J., Teague C., Potchen N. et al., 2021/06/15. Journal of immunology, 206 (12) pp. 2937-2948. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13570207C1EA]
 
Phylogenetic Cluster Analysis Identifies Virological and Behavioral Drivers of Human Immunodeficiency Virus Transmission in Men Who Have Sex With Men.
Bachmann N., Kusejko K., Nguyen H., Chaudron S.E., Kadelka C., Turk T., Böni J., Perreau M., Klimkait T., Yerly S. et al., 2021/06/15. Clinical infectious diseases, 72 (12) pp. 2175-2183. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_8580D2E23497]
Macroautophagy in lymphatic endothelial cells inhibits T cell-mediated autoimmunity.
Harlé G., Kowalski C., Dubrot J., Brighouse D., Clavel G., Pick R., Bessis N., Niven J., Scheiermann C., Gannagé M. et al., 2021/06/07. The Journal of experimental medicine, 218 (6) pp. e20201776. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_44434EB79885]
 
Immune deficiency, autoimmune disease and intellectual disability: A pleiotropic disorder caused by biallelic variants in the TPP2 gene.
Atallah I., Quinodoz M., Campos-Xavier B., Peter V.G., Fouriki A., Bonvin C., Bottani A., Kumps C., Angelini F., Bellutti Enders F. et al., 2021/06. Clinical genetics, 99 (6) pp. 780-788. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_ED69F497CA09]
Systematic screening of viral and human genetic variation identifies antiretroviral resistance and immune escape link.
Nguyen H., Thorball C.W., Fellay J., Böni J., Yerly S., Perreau M., Hirsch H.H., Kusejko K., Thurnheer M.C., Battegay M. et al., 2021/06/01. eLife, 10. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CDF338C143A7]
 
Autologous Ex Vivo Lentiviral Gene Therapy for Adenosine Deaminase Deficiency.
Kohn D.B., Booth C., Shaw K.L., Xu-Bayford J., Garabedian E., Trevisan V., Carbonaro-Sarracino D.A., Soni K., Terrazas D., Snell K. et al., 2021/05/27. The New England journal of medicine, 384 (21) pp. 2002-2013. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B0DDF70ABF8F]
 
Acquisition of optimal TFH cell function is defined by specific molecular, positional, and TCR dynamic signatures.
Padhan K., Moysi E., Noto A., Chassiakos A., Ghneim K., Perra M.M., Shah S., Papaioannou V., Fabozzi G., Ambrozak D.R. et al., 2021/05/04. Proceedings of the National Academy of Sciences of the United States of America, 118 (18) pp. e2016855118. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A4C000AF4D9]
 
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy.
Ghisoni E., Wicky A., Bouchaab H., Imbimbo M., Delyon J., Gautron Moura B., Gérard C.L., Latifyan S., Özdemir B.C., Caikovski M. et al., 2021/05. European journal of cancer, 149 pp. 153-164. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4791AD7F437D]
 
Recent progress and remaining hurdles toward clinical xenotransplantation.
Meier RPH, Longchamp A., Mohiuddin M., Manuel O., Vrakas G., Maluf D.G., Buhler L.H., Muller Y.D., Pascual M., 2021/05. Xenotransplantation, 28 (3) pp. e12681. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3232FC94FF85]
 
Using longitudinally sampled viral nucleotide sequences to characterize the drivers of HIV-1 transmission.
Reichmuth M.L., Chaudron S.E., Bachmann N., Nguyen H., Böni J., Metzner K.J., Perreau M., Klimkait T., Yerly S., Hirsch H.H. et al., 2021/05. HIV medicine, 22 (5) pp. 346-359. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5172F8884D30]
 
Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans.
Seaton K.E., Deal A., Han X., Li S.S., Clayton A., Heptinstall J., Duerr A., Allen M.A., Shen X., Sawant S. et al., 2021/04/15. NPJ vaccines, 6 (1) p. 56. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F71F6A9EA243]
 
A Randomized Placebo-Controlled Efficacy Study of a Prime Boost Therapeutic Vaccination Strategy in HIV-1-Infected Individuals: VRI02 ANRS 149 LIGHT Phase II Trial.
Lévy Y., Lacabaratz C., Lhomme E., Wiedemann A., Bauduin C., Fenwick C., Foucat E., Surenaud M., Guillaumat L., Boilet V. et al., 2021/04/12. Journal of virology, 95 (9) pp. e02165-20. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6673B3848E48]
 
Implementing SARS-CoV-2 Rapid Antigen Testing in the Emergency Ward of a Swiss University Hospital: The INCREASE Study.
Caruana G., Croxatto A., Kampouri E., Kritikos A., Opota O., Foerster M., Brouillet R., Senn L., Lienhard R., Egli A. et al., 2021/04/10. Microorganisms, 9 (4) p. 798. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0FC767B1B433]
Biologiques et lupus érythémateux systémique : nouveautés et perspectives [Biologics and systemic lupus erythematosous : new insights and perspectives]
Clottu A., Horisberger A., Comte D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 684-689. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F63846A94F19]
Donnez-nous aujourd’hui nos chiffres quotidiens !
Seebach J.D., Ribi C., 2021/04/07. Revue medicale suisse, 17 (733) pp. 667-668. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_19DAE61EF00C]
Une allergie insolite : le syndrome cannabis-fruits et legumes [An unusual allergy : cannabis-fruit and vegetable syndrome]
Ringwald M., Moi L., Muller Y.D., Ribi C., 2021/04/07. Revue medicale suisse, 17 (733) pp. 680-683. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5ED8677C34FC]
 
Vaccins contre le Covid-19 : cibles vaccinales, immunogénicité et réactions allergiques [COVID-19 vaccines: vaccine targets, immunogenicity and allergic reactions]
Fallet B., Miauton A., Comte D., Ribi C., Muller Y.D., 2021/04/07. Revue medicale suisse, 17 (733) pp. 690-696.
[DOI][Pmid][serval:BIB_C0A9B3C05FF4]
 
Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition.
Corey L., Gilbert P.B., Juraska M., Montefiori D.C., Morris L., Karuna S.T., Edupuganti S., Mgodi N.M., deCamp A.C., Rudnicki E. et al., 2021/03/18. The New England journal of medicine, 384 (11) pp. 1003-1014. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6D90AB8B1CE0]
Syndrome de Sjögren : du diagnostic au traitement [Sjögren's syndrome: from diagnosis to treatment]
Dumusc A., Ribi C., 2021/03/10. Revue medicale suisse, 17 (729) pp. 477-480. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9ABBC59CBCE2]
 
Chimeric antigen receptor T-cell therapy for HIV cure.
Alfageme-Abello O., Porret R., Perreau M., Perez L., Muller Y.D., 2021/03/01. Current opinion in HIV and AIDS, 16 (2) pp. 88-97. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD634884AC0E]
In Situ Characterization of Follicular Helper CD4 T Cells Using Multiplexed Imaging.
Ioannidou K., Ndiaye D.R., Noto A., Fenwick C., Fortis S.P., Pantaleo G., Petrovas C., de Leval L., 2021/02/28. Frontiers in immunology, 11 p. 607626. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0018D6BF0D49]
Complément et rein [Complement system and kidney]
Halfon M., Pascual M., Sadallah S., Fakhouri F., 2021/02/24. Revue medicale suisse, 17 (727) pp. 383-388. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_83627E067A3D]
COVID-19 pédiatrique - Pathophysiologie, réponses immunitaires, prédispositions génétiques et syndrome hyperinflammatoire [Pediatric COVID-19 - Pathophysiology, immune responses, genetic predispositions, hyperinflammatory syndrome]
Blanchard-Rohner G., Pachlopnik Schmid J., Candotti F., Hofer M., 2021/02/17. Revue medicale suisse, 17 (726) pp. 334-337. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_7C258D1A476B]
Personalized Cytokine-Directed Therapy With Tocilizumab for Refractory Immune Checkpoint Inhibitor-Related Cholangiohepatitis.
Moi L., Bouchaab H., Mederos N., Nguyen-Ngoc T., Perreau M., Fenwick C., Vaucher J., Sempoux C., Peters S., Obeid M., 2021/02. Journal of thoracic oncology, 16 (2) pp. 318-326. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3FFE3BA356BB]
Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
Tumbo A.M., Schindler T., Dangy J.P., Orlova-Fink N., Bieri J.R., Mpina M., Milando F.A., Juma O., Hamad A., Nyakarungu E. et al., 2021/01/26. Virology journal, 18 (1) p. 28. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A3C8AF5A0185]
 
Phase 1 Human Immunodeficiency Virus (HIV) Vaccine Trial to Evaluate the Safety and Immunogenicity of HIV Subtype C DNA and MF59-Adjuvanted Subtype C Envelope Protein.
Hosseinipour M.C., Innes C., Naidoo S., Mann P., Hutter J., Ramjee G., Sebe M., Maganga L., Herce M.E., deCamp A.C. et al., 2021/01/23. Clinical infectious diseases, 72 (1) pp. 50-60. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_51B64C338E47]
Allergologie-immunologie - Rhinosinusite chronique avec polypes nasaux : quelle est la place des anticorps monoclonaux en 2020 ? [Chronic rhinosinusitis with nasal polyps : is there a place for monoclonal antibodies in 2020 ?]
Clottu A., Reinhard A., Comte D., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 13-17. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_6983B434CAF0]
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies.
Fenwick C., Croxatto A., Coste A.T., Pojer F., André C., Pellaton C., Farina A., Campos J., Hacker D., Lau K. et al., 2021/01/13. Journal of virology, 95 (3) pp. e01828-20. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_95BA21CCB9C1]
Pédiatrie - Dépistage des nouveau-nés en Suisse pour les déficiences sévères à lymphocytes T et B [Newborn screening for severe T and B lymphocyte deficiencies in Switzerland]
Fouriki A., Schnider C., Theodoropoulou K., Pachlopnik J., Hofer M., Candotti F., 2021/01/13. Revue medicale suisse, 17 (720-1) pp. 68-76. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_35F00EC79F4E]
ARIA digital anamorphosis: Digital transformation of health and care in airway diseases from research to practice.
Bousquet J., Anto J.M., Bachert C., Haahtela T., Zuberbier T., Czarlewski W., Bedbrook A., Bosnic-Anticevich S., Walter Canonica G., Cardona V. et al., 2021/01. Allergy, 76 (1) pp. 168-190. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D8B6EDEEE822]
Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider.
Solari D., Alberio L., Ribi C., Grandoni F., Stalder G., 2021/01. TH open, 5 (1) pp. e8-e13. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_40479FDB0A11]
 
Autoimmune hepatitis as a sequelae of oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms.
Droz N., Chevrier F., Lapointe A.K., Sempoux C., Fraga M., Comte D., 2021/01. The journal of allergy and clinical immunology. In practice, 9 (1) pp. 580-581. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3F757D73A9EF]
 
CAR T-Cell Therapy: Is CD28-CAR Heterodimerization Its Achilles' Heel?
Ferreira LMR, Muller Y.D., 2021. Frontiers in immunology, 12 p. 766220. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FD79D8B405D7]
Case Report: A Rare Truncating Variant of the CFHR5 Gene in IgA Nephropathy.
Guzzo G., Sadallah S., Fodstad H., Venetz J.P., Rotman S., Teta D., Gauthier T., Pantaleo G., Superti-Furga A., Pascual M., 2021. Frontiers in genetics, 12 p. 529236. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AA15A6D9CD84]
Case Report: SARS-CoV-2 as an unexpected causal agent of predominant febrile hepatitis.
Filippidis P., van Ouwenaller F., Cerutti A., Geiger-Jacquod A., Sempoux C., Pantaleo G., Moradpour D., Lamoth F., 2021. F1000Research, 10 p. 400. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0194C4870252]
Case Report: Stepwise Anti-Inflammatory and Anti-SARS-CoV-2 Effects Following Convalescent Plasma Therapy With Full Clinical Recovery.
Zimmerli A., Monti M., Fenwick C., Eckerle I., Beigelman-Aubry C., Pellaton C., Jaton K., Dumas D., Stamm G.M., Infanti L. et al., 2021. Frontiers in immunology, 12 p. 613502. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE27E1EE2E3C]
Demographics and outcomes of hepatitis B and D: A 10-year retrospective analysis in a Swiss tertiary referral center.
Vieira Barbosa J., Sahli R., Aubert V., Chaouch A., Moradpour D., Fraga M., 2021. PloS one, 16 (4) pp. e0250347. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5339E3BF898D]
Inducible HIV-1 Reservoir Quantification: Clinical Relevance, Applications and Advancements of TILDA.
Lungu C., Banga R., Gruters R.A., Procopio F.A., 2021. Frontiers in microbiology, 12 p. 686690. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A21399B21CA2]
Infectious complications and graft outcome following treatment of acute antibody-mediated rejection after kidney transplantation: A nationwide cohort study.
Perrottet N., Fernández-Ruiz M., Binet I., Dickenmann M., Dahdal S., Hadaya K., Müller T., Schaub S., Koller M., Rotman S. et al., 2021. PloS one, 16 (4) pp. e0250829. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8D676A182CA8]
Innate Lymphoid Cells in Autoimmune Diseases.
Clottu A.S., Humbel M., Fluder N., Karampetsou M.P., Comte D., 2021. Frontiers in immunology, 12 p. 789788. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2DE35917C405]
Novel Discoveries in Immune Dysregulation in Inborn Errors of Immunity.
Ren A., Yin W., Miller H., Westerberg L.S., Candotti F., Park C.S., Lee P., Gong Q., Chen Y., Liu C., 2021. Frontiers in immunology, 12 p. 725587. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_5ABC78DF7B11]
Restoration of NK Cell Cytotoxic Function With Elotuzumab and Daratumumab Promotes Elimination of Circulating Plasma Cells in Patients With SLE.
Humbel M., Bellanger F., Fluder N., Horisberger A., Suffiotti M., Fenwick C., Ribi C., Comte D., 2021. Frontiers in immunology, 12 p. 645478. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_27C3800011DA]
 
Revaccination of persons with an immediate reaction after the first dose of mRNA COVID-19 vaccine
Stehlin F., Canton L., Girard C., Miauton A., Santos A., Genoud P., Ribi C., Meylan S., Muller Y. D., 2021. pp. 516-517 dans Abstracts from the European Academy of Allergy and Clinical Immunology Hybrid Congress, 10-12 July 2021, Allergy.
[DOI][serval:BIB_72B4A659BAD4]
The CD28-Transmembrane Domain Mediates Chimeric Antigen Receptor Heterodimerization With CD28.
Muller Y.D., Nguyen D.P., Ferreira LMR, Ho P., Raffin C., Valencia RVB, Congrave-Wilson Z., Roth T.L., Eyquem J., Van Gool F. et al., 2021. Frontiers in immunology, 12 p. 639818. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_35407AE1906E]
Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected Patients.
Bibert S., Guex N., Lourenco J., Brahier T., Papadimitriou-Olivgeris M., Damonti L., Manuel O., Liechti R., Götz L., Tschopp J. et al., 2021. Frontiers in immunology, 12 p. 666163. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_91CEC9119F7E]
2020
 
Treatment of allergic rhinitis during and outside the pollen season using mobile technology. A MASK study.
Bédard A., Basagaña X., Anto J.M., Garcia-Aymerich J., Devillier P., Arnavielhe S., Bedbrook A., Onorato G.L., Czarlewski W., Murray R. et al., 2020/12/09. Clinical and translational allergy, 10 (1) p. 62. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E405DA99926C]
 
Cytokine-directed therapy with tocilizumab for immune checkpoint inhibitor-related hemophagocytic lymphohistiocytosis.
Özdemir B.C., Latifyan S., Perreau M., Fenwick C., Alberio L., Waeber G., Spertini F., de Leval L., Michielin O., Obeid M., 2020/12. Annals of oncology, 31 (12) pp. 1775-1778. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_DC85C792AD0C]
 
Host Genomics of the HIV-1 Reservoir Size and Its Decay Rate During Suppressive Antiretroviral Treatment.
Thorball C.W., Borghesi A., Bachmann N., Von Siebenthal C., Vongrad V., Turk T., Neumann K., Beerenwinkel N., Bogojeska J., Roth V. et al., 2020/12/01. Journal of acquired immune deficiency syndromes, 85 (4) pp. 517-524. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_FDF7A2D4587F]
Rationally designed Human Cytomegalovirus gB nanoparticle vaccine with improved immunogenicity.
Perotti M., Marcandalli J., Demurtas D., Sallusto F., Perez L., 2020/12. PLoS pathogens, 16 (12) pp. e1009169. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_711970C96BE8]
Utility of D-dimers and intermediate-dose prophylaxis for venous thromboembolism in critically ill patients with COVID-19
Zermatten Maxime G., Pantet Olivier, Gomez Francisco, Schneider Antoine, Méan Marie, Mazzolai Lucia, Hugli Olivier, Bart Pierre-Alexandre, Papadimitriou-Olivgeris Matthaios, Alberio Lorenzo, 2020/12. Thrombosis Research, 196 pp. 222-226. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_8BF1D4A9E075]
 
Effets indésirables immunomédiés des inhibiteurs de points de contrôle immunitaire: point de vue de l’interniste [Immune-related adverse events of checkpoint inhibitors: an internist/general practitioner's point of view]
Cisarovsky C., Kraege V., Obeid M., Garnier A., 2020/11/25. Revue medicale suisse, 16 (716) pp. 2264-2270. Peer-reviewed.
[DOI][Pmid][serval:BIB_DE32CC592446]
 
BCG Vaccination Induces Long-Term Functional Reprogramming of Human Neutrophils.
Moorlag SJCFM, Rodriguez-Rosales Y.A., Gillard J., Fanucchi S., Theunissen K., Novakovic B., de Bont C.M., Negishi Y., Fok E.T., Kalafati L. et al., 2020/11/17. Cell reports, 33 (7) p. 108387. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7370314447E5]
 
Interprétation du dosage des anticorps anti-phospholipides
Nozic Adnan, Burger Raphael, Alberio Lorenzo, Ribi Camillo, 2020/11/03. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum.
[DOI][serval:BIB_BA768D65F04C]
Heritability of the HIV-1 reservoir size and decay under long-term suppressive ART.
Wan C., Bachmann N., Mitov V., Blanquart F., Céspedes S.P., Turk T., Neumann K., Beerenwinkel N., Bogojeska J., Fellay J. et al., 2020/11/02. Nature communications, 11 (1) p. 5542. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EC2E5183286F]
Multisystem inflammatory syndrome with refractory cardiogenic shock due to acute myocarditis and mononeuritis multiplex after SARS-CoV-2 infection in an adult.
Othenin-Girard A., Regamey J., Lamoth F., Horisberger A., Glampedakis E., Epiney J.B., Kuntzer T., de Leval L., Carballares M., Hurni C.A. et al., 2020/11/02. Swiss medical weekly, 150 pp. w20387. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_135A96CD7E72]
 
Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID) in the US Immunodeficiency Network (USIDNet) Registry.
Kuo C.Y., Garabedian E., Puck J., Cowan M.J., Sullivan K.E., Buckley R.H., Cunningham-Rundles C., Marsh R., Candotti F., Kohn D.B., 2020/11. Journal of clinical immunology, 40 (8) pp. 1124-1131. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D4F5DD043A76]
 
Identification of highly active systemic lupus erythematosus by combined type I interferon and neutrophil gene scores vs classical serologic markers.
Chasset F., Ribi C., Trendelenburg M., Huynh-Do U., Roux-Lombard P., Courvoisier D.S., Chizzolini C., Swiss SLE Cohort Study (SSCS, 2020/11/01. Rheumatology, 59 (11) pp. 3468-3478. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4A8762699A3C]
 
TLR-9 agonist and CD40-targeting vaccination induces HIV-1 envelope-specific B cells with a diversified immunoglobulin repertoire in humanized mice.
Godot V., Tcherakian C., Gil L., Cervera-Marzal I., Li G., Cheng L., Ortonne N., Lelièvre J.D., Pantaleo G., Fenwick C. et al., 2020/11. PLoS pathogens, 16 (11) pp. e1009025. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_772249C57318]
 
Allergen-Immuntherapie in der aktuellen COVID-19-Pandemie – ein Positionspapier von ARIA, EAACI, AeDA, GPA und DGAKI (Kurzversion) – Positionspapier der deutschen ARIA-GruppeA in Kooperation mit der österreichischen ARIA-GruppeB, der schweizerischen ARIA-GruppeC, dem Ärzteverband Deutscher Allergologen (AeDA)D, der Deutschen Gesellschaft für Allergologie und Klinische Immunologie (DGAKI)E und der Gesellschaft für Pädiatrische Allergologie (GPA)F in Kooperation mit der AG Klinische Immunologie, Allergologie und Umweltmedizin der DGHNO-KHCG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H [Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI-AeDA-GPA-DGAKI Position Paper (Pocket-Guide)]
Pfaar O., Klimek L., Worm M., Bergmann K.C., Bieber T., Buhl R., Buters J., Darsow U., Keil T., Kleine-Tebbe J. et al., 2020/10. Laryngo- rhino- otologie, 99 (10) pp. 676-679. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4AB6956792D7]
 
ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis.
Horisberger A., Pantazou V., Cuendet G., Ribi C., Dunet V., Théaudin M., 2020/10. Multiple sclerosis, 26 (12) pp. 1599-1602. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_90C58633C44F]
 
Busulfan Pharmacokinetics in Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Gene Therapy.
Bradford K.L., Liu S., Krajinovic M., Ansari M., Garabedian E., Tse J., Wang X., Shaw K.L., Gaspar H.B., Candotti F. et al., 2020/10. Biology of blood and marrow transplantation, 26 (10) pp. 1819-1827. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BA60F08CDFC]
Inter-Laboratory Reproducibility of Inducible HIV-1 Reservoir Quantification by TILDA.
Lungu C., Procopio F.A., Overmars R.J., Beerkens RJJ, Voermans JJC, Rao S., Prins HAB, Rokx C., Pantaleo G., Vijver DAMCV et al., 2020/09/02. Viruses, 12 (9) pp. E973. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_FA8B8D55233A]
 
Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A., Joseph A., Pagnoux C., Puéchal X., Cohen P., Samson M., Hamidou M., Karras A., Quemeneur T., Ribi C. et al., 2020/09/01. Rheumatology, 59 (9) p. 2653. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF8BF6CB3CF7]
 
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study Group.
Lafarge A., Joseph A., Pagnoux C., Puéchal X., Cohen P., Samson M., Hamidou M., Karras A., Quemeneur T., Ribi C. et al., 2020/09/01. Rheumatology, 59 (9) pp. 2250-2257. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_BF7E60D17419]
 
Progressive multifocal leukoencephalopathy responsive to withdrawal of imatinib in a patient with FIP1L1-PDGFRA positive myeloid neoplasm.
Blum S., Dunet V., Comoli P., Tirefort Y., Chalandon Y., Opota O., Comte D., Spertini O., Livio F., Brouland J.P. et al., 2020/09. Leukemia & lymphoma, 61 (9) pp. 2226-2229. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_13EB95E6B61C]
Tocilizumab for refractory severe immune checkpoint inhibitor-associated myocarditis.
Doms J., Prior J.O., Peters S., Obeid M., 2020/09. Annals of oncology, 31 (9) pp. 1273-1275. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_36FA44B46F63]
Guillain-Barré syndrome after adoptive cell therapy with tumor-infiltrating lymphocytes.
Orcurto A., Hottinger A., Wolf B., Navarro Rodrigo B., Ochoa de Olza M., Auger A., Kuntzer T., Comte D., Zimmer V., Gannon P. et al., 2020/08. Journal for immunotherapy of cancer, 8 (2) pp. e001155. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C930B13A53AD]
 
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohort
Mihai Carina, Distler Oliver, Gheorghiu Ana Maria, Constantin Paul I, Dobrota Rucsandra, Jordan Suzana, Smith Vanessa, Hachulla Eric, Henes Jörg, Siegert Elise et al., 2020/08/01. Rheumatology, 59 (8) pp. 2016-2023.
[DOI][WoS][Pmid][serval:BIB_07BEDE96F20E]
 
Personalized treatment of immune-related adverse events - balance is required.
Martins F., Obeid M., 2020/08. Nature reviews. Clinical oncology, 17 (8) p. 517. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_483DF1AA5D60]
 
PTPN2 Deficiency Enhances Programmed T Cell Expansion and Survival Capacity of Activated T Cells.
Flosbach M., Oberle S.G., Scherer S., Zecha J., von Hoesslin M., Wiede F., Chennupati V., Cullen J.G., List M., Pauling J.K. et al., 2020/07/28. Cell reports, 32 (4) p. 107957. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B80C87024EE0]
 
Blood and Lymph Node Dissemination of Clonal Genome-Intact Human Immunodeficiency Virus 1 DNA Sequences During Suppressive Antiretroviral Therapy.
Kuo H.H., Banga R., Lee G.Q., Gao C., Cavassini M., Corpataux J.M., Blackmer J.E., Zur Wiesch S., Yu X.G., Pantaleo G. et al., 2020/07/23. The Journal of infectious diseases, 222 (4) pp. 655-660. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D6B879F20B5C]
Racisme et pratique de la médecine : éléments pour un apprentissage nécessaire [Racism and the practice of medicine : elements for a required learning]
Bodenmann P., Hrasnica F., Prod'hom D., Perrin È.M., Ishii A., Porret R., Fricker C., Morisod K., Sanchis Zozaya J., Malebranche M.E. et al., 2020/07/15. Revue medicale suisse, 16 (700) pp. 1373-1379. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_51045F137D37]
A case report on the cytokine signature profile of immunoglobulin G4-related disease.
Dällenbach J., Moi L., Humair G., Letovanec I., Perreau M., Cherix S., Comte D., Vaucher J., 2020/07. Scandinavian journal of rheumatology, 49 (4) pp. 332-333. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6E2119D540C3]
Collapsing glomerulopathy in a COVID-19 patient.
Kissling S., Rotman S., Gerber C., Halfon M., Lamoth F., Comte D., Lhopitallier L., Sadallah S., Fakhouri F., 2020/07. Kidney international, 98 (1) pp. 228-231. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_251429356BF9]
Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
Schwotzer N., Paganetti G., Barchi M., Perrottet N., Aubert V., Sadallah S., Rotman S., Venetz J.P., Matter M., Golshayan D. et al., 2020/07. Xenotransplantation, 27 (4) pp. e12630. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_119F4B750A1D]
Cardiotoxicité des inhibiteurs de points de contrôle immunitaire utilisés dans le traitement des cancers [Cardiotoxicity of immune checkpoint inhibitors used in cancer treatment]
Arangalage D., Pavon A.G., Hugelshofer S., Desgraz B., Tzimas G., Delyon J., Muller O., Obeid M., Ribi C., Michielin O. et al., 2020/06/03. Revue medicale suisse, 16 (696) pp. 1165-1168. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_A124D4D50BD9]
 
Autoantibody Signature in Cardiac Arrest.
Maguy A., Tardif J.C., Busseuil D., Ribi C., Li J., 2020/06/02. Circulation, 141 (22) pp. 1764-1774. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_57EE7E68DB9A]
 
Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy.
Haanen J., Ernstoff M.S., Wang Y., Menzies A.M., Puzanov I., Grivas P., Larkin J., Peters S., Thompson J.A., Obeid M., 2020/06. Annals of oncology, 31 (6) pp. 724-744. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_4BA2439C7A4C]
 
Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial.
Lévy Y., Lacabaratz C., Ellefsen-Lavoie K., Stöhr W., Lelièvre J.D., Bart P.A., Launay O., Weber J., Salzberger B., Wiedemann A. et al., 2020/06. PLoS pathogens, 16 (6) pp. e1008522. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_82AFFC2A801F]
Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy.
Haanen J., Ernstoff M., Wang Y., Menzies A., Puzanov I., Grivas P., Larkin J., Peters S., Thompson J., Obeid M., 2020/06. Journal for immunotherapy of cancer, 8 (1) pp. e000604. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D60E64350838]
 
Antibody and cellular responses to HIV vaccine regimens with DNA plasmid as compared with ALVAC priming: An analysis of two randomized controlled trials.
Moodie Z., Walsh S.R., Laher F., Maganga L., Herce M.E., Naidoo S., Hosseinipour M.C., Innes C., Bekker L.G., Grunenberg N. et al., 2020/05. PLoS medicine, 17 (5) pp. e1003117. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_69F33465D212]
COVID-19 and lung cancer: risks, mechanisms and treatment interactions.
Addeo A., Obeid M., Friedlaender A., 2020/05. Journal for immunotherapy of cancer, 8 (1) pp. e000892. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_03895CF65905]
Impact of COVID-19 pandemic on SLE: beyond the risk of infection.
Horisberger A., Moi L., Ribi C., Comte D., 2020/05. Lupus science & medicine, 7 (1). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2CCD571AE26B]
Impacts organisationnels et défis cliniques de la pandémie COVID-19 pour un service hospitalier de médecine interne universitaire [Organizational Impacts and Clinical Challenges of the COVID-19 Pandemic on a Swiss Tertiary Internal Medicine Department]
Garnier A., Vaucher J., Bianchi C., Kraege V., Méan M., Castioni J., Bart P.A., Champier V., Eggimann P., Gachoud D. et al., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 869-874. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C4B18AADE722]
Maladies autoimmunes dans le contexte de la pandémie COVID-19 [Autoimmune diseases in the context of pandemic COVID-19]
Horisberger A., Moi L., Ribi C., Comte D., 2020/04/29. Revue medicale suisse, 16 (N° 691-2) pp. 827-830. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_23C4ADC982B0]
 
Intra-uterine growth restriction induced by maternal low-protein diet causes long-term alterations of thymic structure and function in adult male rat offspring.
Armengaud J.B., Dennebouy Z., Labes D., Fumey C., Wilson A., Candotti F., Yzydorczyk C., Simeoni U., 2020/04/28. The British journal of nutrition, 123 (8) pp. 892-900. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CAF70B17A491]
Allergies aux animaux à poils : mythes et réalités [Allergy to furry animals: myth and reality]
Clottu A., Mahdi Aljedani R., Spertini F., 2020/04/08. Revue medicale suisse, 16 (689) pp. 688-693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_83DB6FA41060]
Angiœdèmes héréditaires sur ­déficit en C1-inhibiteur : nouveautés ­thérapeutiques [Hereditary angioedema due to C1-esterase inhibitor deficiency : novel approaches]
Stehlin F., Ribi C., 2020/04/08. Revue medicale suisse, 16 (689) pp. 675-678. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_5093AD198998]
Jamais sans mon chat !
Spertini F., Seebach J., 2020/04/08. Revue medicale suisse, 16 (689) pp. 667-668. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_1257DDFAAC1A]
Prise en charge du syndrome des ­anticorps antiphospholipides chez l’adulte [Management of the antiphospholipid syndrome in adults]
Doms J., Horisberger A., Ribi C., 2020/04/08. Revue medicale suisse, 16 (689) pp. 670-674. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_F55407187560]
 
Anti-apolipoprotein A-1 autoantibodies correlate with disease activity in systemic lupus erythematosus.
Nigolian H., Ribi C., Courvoisier D.S., Pagano S., Alvarez M., Trendelenburg M., Huynh-Do U., Vuilleumier N., Dayer J.M., Chizzolini C. et al., 2020/03/01. Rheumatology, 59 (3) pp. 534-544. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B6968F86D374]
 
Hémorragie intra-alvéolaire induite par le propylthiouracil
Desmercières Jérémy, Ribi Camillo, Azarnoush Kouchiar, Liaudet Lucas, Matter Maurice, Ribordy et Vincent, 2020/03. La Presse Médicale Formation, 1 (1) pp. 73-76.
[DOI][serval:BIB_4AFFCFFD26E1]
Management of allergy transfer upon solid organ transplantation.
Muller Y.D., Vionnet J., Beyeler F., Eigenmann P., Caubet J.C., Villard J., Berney T., Scherer K., Spertini F., Fricker M.P. et al., 2020/03. American journal of transplantation, 20 (3) pp. 834-843. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B4CCBADEDA6A]
 
Metabolomics and allergy: Opening Pandora's box.
Spertini F., 2020/03. The Journal of allergy and clinical immunology, 145 (3) pp. 782-784. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D065EB65E0BB]
 
Risk of malignancy in patients treated for systemic necrotising vasculitis.
Lafarge A., Joseph A., Pagnoux C., Puechal X., Cohen P., Samson M., Hamidou M., Karras A., Groh M., Quemeneur T. et al., 2020/03. Annals of the rheumatic diseases, 79 (3) pp. 431-433. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6ABEE6226AA2]
No association of complement mannose-binding lectin deficiency with cardiovascular disease in patients with Systemic Lupus Erythematosus.
Kieninger-Gräfitsch A., Vogt S., Ribi C., Dubler D., Chizzolini C., Huynh-Do U., Osthoff M., Trendelenburg M., 2020/02/28. Scientific reports, 10 (1) p. 3693. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C2236827B475]
 
Une polyarthrite fébrile récidivante
Konasch Andreas, Lu Henri, Rousakis Markos, Comte Denis, Ribi Camillo, 2020/02/25. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_C86F8FA697A1]
 
Trop de Troponines
Kohli Ribeiro Stphanie, Delabays Alain, Ribi Camillo, Sartori Claudio, 2020/02/11. Forum Médical Suisse ‒ Swiss Medical Forum.
[DOI][serval:BIB_0CB95B589339]
 
A Diffuse Medullary Hypercaptation With No Bone Lesion.
Christin A., de Leval L., Obeid M., 2020/02/01. JAMA oncology, 6 (2) pp. 291-292. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_CCEF961A6931]
 
The complex challenges of HIV vaccine development require renewed and expanded global commitment.
Bekker L.G., Tatoud R., Dabis F., Feinberg M., Kaleebu P., Marovich M., Ndung'u T., Russell N., Johnson J., Luba M. et al., 2020/02/01. Lancet, 395 (10221) pp. 384-388. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_1C05F2A23A5B]
PROFILES: portrait-type de nos futurs médecins ! [PROFILES: typical portrait of the future Swiss doctors]
Bart P.A., Monti M., Gachoud D., Félix S., Turpin D., Marino L., Takeuchi Y.L., Senn N., Sohrmann M., 2020/01/22. Revue medicale suisse, 16 (678) pp. 133-137. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AD9A2E8336CF]
 
Emergence of Drug Resistance in the Swiss HIV Cohort Study Under Potent Antiretroviral Therapy Is Observed in Socially Disadvantaged Patients.
Abela I.A., Scherrer A.U., Böni J., Yerly S., Klimkait T., Perreau M., Hirsch H.H., Furrer H., Calmy A., Schmid P. et al., 2020/01/02. Clinical infectious diseases, 70 (2) pp. 297-303. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_5CD4824E50AC]
 
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA
Klimek L., Pfaar O., Worm M., Bergmann K.C., Bieber T., Buhl R., Buters J., Darsow U., Keil T., Kleine-Tebbe J. et al., 2020. Allergologie select, 4 pp. 44-52. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D31405FF5EB8]
 
Allergen-Immuntherapie in der aktuellen Covid-19-Pandemie
Klimek L., Pfaar O., Worm M., Bergmann K.C., Bieber T., Buhl R., Buters J., Darsow U., Keil T., Kleine-Tebbe J. et al., 2020. Allergo Journal, 29 (3) pp. 17-25. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_50E9A161B5BC]
Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure.
Vigano S., Bobisse S., Coukos G., Perreau M., Harari A., 2020. Frontiers in immunology, 11 p. 1350. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_19C82F6CB34E]
 
Designs and Characterization of Subunit Ebola GP Vaccine Candidates: Implications for Immunogenicity.
Agnolon V., Kiseljak D., Wurm M.J., Wurm F.M., Foissard C., Gallais F., Wehrle S., Muñoz-Fontela C., Bellanger L., Correia B.E. et al., 2020. Frontiers in immunology, 11 p. 586595. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_AD44132F37DC]
 
Differences in social and mental well-being of long-term survivors among people who inject drugs and other participants in the Swiss HIV Cohort Study: 1980-2018.
Kusejko K., Marzel A., Nguyen H., Chaudron S.E., Bachmann N., Weber R., Bruggmann P., Roth J.A., Bernasconi E., Calmy A. et al., 2020. Antiviral therapy, 25 (1) pp. 43-54. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_957CA76EF559]
 
Epitope Mapping and Fine Specificity of Human T and B Cell Responses for Novel Candidate Blood-Stage Malaria Vaccine P27A.
Geiger K.M., Guignard D., Yang C., Bikorimana J.P., Correia B.E., Houard S., Mkindi C., Daubenberger C.A., Spertini F., Corradin G. et al., 2020. Frontiers in immunology, 11 p. 412. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_941F355259B5]
Neurologic complications of acute hepatitis E virus infection.
Ripellino P., Pasi E., Melli G., Staedler C., Fraga M., Moradpour D., Sahli R., Aubert V., Martinetti G., Bihl F. et al., 2020/01. Neurology, 7 (1) pp. e643. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_7824310363C5]
 
P. falciparum and P. vivax Orthologous Coiled-Coil Candidates for a Potential Cross-Protective Vaccine.
Ayadi I., Balam S., Audran R., Bikorimana J.P., Nebie I., Diakité M., Felger I., Tanner M., Spertini F., Corradin G. et al., 2020. Frontiers in immunology, 11 p. 574330. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_00B3708CAEEE]
 
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy.
Rentsch C.A., Bosshard P., Mayor G., Rieken M., Püschel H., Wirth G., Cathomas R., Parzmair G.P., Grode L., Eisele B. et al., 2020. Oncoimmunology, 9 (1) p. 1748981. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F69BE76B77FF]
Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
Govender L., Mikulic J., Wyss J.C., Gaide O., Thome M., Golshayan D., 2020. Frontiers in immunology, 11 p. 576651. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_67419B803F44]
 
Use of biologicals in allergic and type-2 inflammatory diseases during the current COVID-19 pandemic
Klimek L., Pfaar O., Worm M., Eiwegger T., Hagemann J., Ollert M., Untersmayr E., Hoffmann-Sommergruber K., Vultaggio A., Agache I. et al., 2020. Allergologie select, 4 pp. 53-68. Peer-reviewed.
[DOI][Pmid][serval:BIB_CB542E8C634A]
2019
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.
Giel-Moloney M., Esteban M., Oakes B.H., Vaine M., Asbach B., Wagner R., Mize G.J., Spies A.G., McElrath J., Perreau M. et al., 2019/12/27. Scientific reports, 9 (1) p. 20005. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_576063A9C68A]
A model for reticular dysgenesis shows impaired sensory organ development and hair cell regeneration linked to cellular stress.
Rissone A., Jimenez E., Bishop K., Carrington B., Slevin C., Wincovitch S.M., Sood R., Candotti F., Burgess S.M., 2019/12/20. Disease models & mechanisms, 12 (12). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_AE7ADE4503CB]
 
A Robust Method for Assaying the Immunoreactive Fraction in Nonequilibrium Systems.
Denoël T., Pedrelli L., Pantaleo G., Prior J.O., 2019/12/03. Pharmaceuticals, 12 (4) pp. E177. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_E07AD7079702]
 
Splicing factor SRSF1 controls T cell hyperactivity and systemic autoimmunity.
Katsuyama T., Li H., Comte D., Tsokos G.C., Moulton V.R., 2019/12/02. The Journal of clinical investigation, 129 (12) pp. 5411-5423. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F5E40706ED4B]
Successful desensitization to pomalidomide in a patient with POEMS syndrome with delayed-type hypersensitivity to immunomodulatory imid drugs.
Grandoni F., Stalder G., Borgeat Kaeser A., Ribi C., Cairoli A., Blum S., 2019/12. Leukemia & lymphoma, 60 (12) pp. 3087-3089. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_A815C7BA260F]
 
Detection of Human Immunodeficiency Virus Type 1 (HIV-1) Antisense Protein (ASP) RNA Transcripts in Patients by Strand-Specific RT-PCR.
Mancarella A., Procopio F.A., Achsel T., De Crignis E., Foley B.T., Corradin G., Bagni C., Pantaleo G., Graziosi C., 2019/11/27. Journal of visualized experiments 153. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_639747930934]
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritis.
Friebus-Kardash J., Trendelenburg M., Eisenberger U., Ribi C., Chizzolini C., Huynh-Do U., Lang K.S., Wilde B., Kribben A., Witzke O. et al., 2019/11/21. BMC nephrology, 20 (1) p. 430. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C34DC9FFCE36]
 
Antigenic competition in CD4+ T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trial
Kallas E.G., Grunenberg N.A., Yu C., Manso B., Pantaleo G., Casapia M., Baden L.R., Valencia J., Sobieszczyk M., Van Tieu H. et al., 2019/11/20. Science translational medicine, 11 (519) pp. eaaw1673. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7B3B2ADF9DB1]
Structural Basis for Broad HIV-1 Neutralization by the MPER-Specific Human Broadly Neutralizing Antibody LN01.
Pinto D., Fenwick C., Caillat C., Silacci C., Guseva S., Dehez F., Chipot C., Barbieri S., Minola A., Jarrossay D. et al., 2019/11/13. Cell host & microbe, 26 (5) pp. 623-637.e8. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_EBC683B64355]
DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.
Rouphael N.G., Morgan C., Li S.S., Jensen R., Sanchez B., Karuna S., Swann E., Sobieszczyk M.E., Frank I., Wilson G.J. et al., 2019/11/01. The Journal of clinical investigation, 129 (11) pp. 4769-4785. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_2E96704E07E0]
Nonvascularized human skin chronic allograft rejection.
Rotman S., Koch N., Wiesner L., Aubert V., Rosales I.A., Colvin R.B., Raffoul W., Pascual M., 2019/11. American journal of transplantation, 19 (11) pp. 3191-3196. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_99FA1291AC19]
Safety and immunogenicity of a multivalent HIV vaccine comprising envelope protein with either DNA or NYVAC vectors (HVTN 096): a phase 1b, double-blind, placebo-controlled trial.
Pantaleo G., Janes H., Karuna S., Grant S., Ouedraogo G.L., Allen M., Tomaras G.D., Frahm N., Montefiori D.C., Ferrari G. et al., 2019/11. The lancet. HIV, 6 (11) pp. e737-e749. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0F89E125D865]
 
T-cell exhaustion in HIV infection.
Fenwick C., Joo V., Jacquier P., Noto A., Banga R., Perreau M., Pantaleo G., 2019/11. Immunological reviews, 292 (1) pp. 149-163. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_09E2A0F1A53D]
 
Variable and inaccurate serum IgG4 levels resulting from lack of standardization in IgG subclass assay calibration.
Bernasconi L., Mundwiler E., Regenass S., Aubert V., Hammerer-Lercher A., Heijnen I., 2019/10/25. Clinical chemistry and laboratory medicine, 57 (11) pp. 1777-1783. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_516FC0573BFB]
Development of a novel human phage display-derived anti-LAG3 scFv antibody targeting CD8+ T lymphocyte exhaustion
Ascione A., Arenaccio C., Mallano A., Flego M., Gellini M., Andreotti M., Fenwick C., Pantaleo G., Vella S., Federico M., 2019/10/17. BMC biotechnology, 19 (1) p. 67. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_712A491B51BD]
 
Supplemental parenteral nutrition improves immunity with unchanged carbohydrate and protein metabolism in critically ill patients: The SPN2 randomized tracer study.
Berger M.M., Pantet O., Jacquelin-Ravel N., Charrière M., Schmidt S., Becce F., Audran R., Spertini F., Tappy L., Pichard C., 2019/10. Clinical nutrition, 38 (5) pp. 2408-2416. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_992C9C7060CA]
 
Safety and tolerance of lymph node biopsies from chronic HIV-1 volunteers in rural Tanzania.
Mkindi C.G., Marandu E.A., Masawa N., Bani F., Nyuri A., Byakuzana T., Klimkait T., Ding S., Pantaleo G., Battegay M. et al., 2019/09/06. BMC research notes, 12 (1) p. 561. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_9D7B18565C63]
 
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance.
Martins F., Sofiya L., Sykiotis G.P., Lamine F., Maillard M., Fraga M., Shabafrouz K., Ribi C., Cairoli A., Guex-Crosier Y. et al., 2019/09. Nature reviews. Clinical oncology, 16 (9) pp. 563-580. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_7F8DDEE8DA1E]
Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
Sobanski V., Giovannelli J., Allanore Y., Riemekasten G., Airò P., Vettori S., Cozzi F., Distler O., Matucci-Cerinic M., Denton C. et al., 2019/09. Arthritis & rheumatology, 71 (9) pp. 1553-1570. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_D5B6E2510518]
Predictors of disease worsening defined by progression of organ damage in diffuse systemic sclerosis: a European Scleroderma Trials and Research (EUSTAR) analysis
Becker Mike, Graf Nicole, Sauter Rafael, Allanore Yannick, Curram John, Denton Christopher P, Khanna Dinesh, Matucci-Cerinic Marco, de Oliveira Pena Janethe, Pope Janet E et al., 2019/09. Annals of the Rheumatic Diseases, 78 (9) pp. 1242-1248.
[URN][DOI][WoS][Pmid][serval:BIB_8A7611119C0A]
 
HIV Transmission Chains Exhibit Greater HLA-B Homogeneity Than Randomly Expected.
Nguyen H., Thorball C.W., Fellay J., Böni J., Yerly S., Perreau M., Klimkait T., Kusejko K., Bachmann N., Chaudron S.E. et al., 2019/08/15. Journal of acquired immune deficiency syndromes, 81 (5) pp. 508-515. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_6E0F5A3E41D4]
The adjuvant GLA-SE promotes human Tfh cell expansion and emergence of public TCRβ clonotypes.
Hill D.L., Pierson W., Bolland D.J., Mkindi C., Carr E.J., Wang J., Houard S., Wingett S.W., Audran R., Wallin E.F. et al., 2019/08/05. The Journal of experimental medicine, 216 (8) pp. 1857-1873. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_B9B6A1FE4844]
 
Corrigendum to “A heterologous prime-boosting strategy with replicating Vaccinia virus vectors and plant-produced HIV-1 Gag/dgp41 virus-like particles” [Virology 507 (2017) 242–256]
Meador Lydia R., Kessans Sarah A., Kilbourne Jacquelyn, Kibler Karen V., Pantaleo Giuseppe, Esteban Mariano, Blattman Joseph N., Jacobs Bertram L., Mor Tsafrir S., 2019/08. 143.
[DOI][WoS][Pmid][serval:BIB_4CBAA702B57A]
Determinants of HIV-1 reservoir size and long-term dynamics during suppressive ART.
Bachmann N., von Siebenthal C., Vongrad V., Turk T., Neumann K., Beerenwinkel N., Bogojeska J., Fellay J., Roth V., Kok Y.L. et al., 2019/07/19. Nature communications, 10 (1) p. 3193. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_E1256C4C82EF]
Macroautophagy in Dendritic Cells Controls the Homeostasis and Stability of Regulatory T Cells.
Niven J., Madelon N., Page N., Caruso A., Harlé G., Lemeille S., Seemayer C.A., Hugues S., Gannagé M., 2019/07/02. Cell reports, 28 (1) pp. 21-29.e6. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_C2E4C1B6EC0D]
 
Efficacy and Adverse Events During Janus Kinase Inhibitor Treatment of SAVI Syndrome.
Volpi S., Insalaco A., Caorsi R., Santori E., Messia V., Sacco O., Terheggen-Lagro S., Cardinale F., Scarselli A., Pastorino C. et al., 2019/07. Journal of clinical immunology, 39 (5) pp. 476-485. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_399FE048032A]
Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement.
Banga R., Rebecchini C., Procopio F.A., Noto A., Munoz O., Ioannidou K., Fenwick C., Ohmiti K., Cavassini M., Corpataux J.M. et al., 2019/07. PLoS pathogens, 15 (7) pp. e1007918. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_1FF4BBBC8958]
 
Outcomes of patients with systemic sclerosis treated with rituximab in contemporary practice: a prospective cohort study
Elhai Muriel, Boubaya Marouane, Distler Oliver, Smith Vanessa, Matucci-Cerinic Marco, Alegre Sancho Juan José, Truchetet Marie-Elise, Braun-Moscovici Yolanda, Iannone Florenzo, Novikov Pavel I et al., 2019/07. Annals of the Rheumatic Diseases, 78 (7) pp. 979-987.
[DOI][WoS][Pmid][serval:BIB_C05206D02249]
 
Signaling lymphocyte activation molecule family in systemic lupus erythematosus.
Comte D., Karampetsou M.P., Humbel M., Tsokos G.C., 2019/07. Clinical immunology, 204 pp. 57-63. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2F4AE7A7E7B6]
Tumor suppression of novel anti-PD-1 antibodies mediated through CD28 costimulatory pathway.
Fenwick C., Loredo-Varela J.L., Joo V., Pellaton C., Farina A., Rajah N., Esteves-Leuenberger L., Decaillon T., Suffiotti M., Noto A. et al., 2019/07/01. The Journal of experimental medicine, 216 (7) pp. 1525-1541. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0B420592FE76]
 
Viral Diversity Based on Next-Generation Sequencing of HIV-1 Provides Precise Estimates of Infection Recency and Time Since Infection.
Carlisle L.A., Turk T., Kusejko K., Metzner K.J., Leemann C., Schenkel C.D., Bachmann N., Posada S., Beerenwinkel N., Böni J. et al., 2019/06/19. The Journal of infectious diseases, 220 (2) pp. 254-265. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_19B3C834E3FA]
Effets indésirables des inhibiteurs de points de contrôle immunitaire : diagnostic et prise en charge [Side effects of immune checkpoint inhibitors: diagnosis and management]
Perrinjaquet C., Zaher M., Ferraro D.A., Comte D., Trueb L., Zimmermann S., Coukos G., Orcurto A., 2019/05/15. Revue medicale suisse, 15 (651) pp. 1010-1016. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_542B193CD99A]
 
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosus.
Pröbstel A.K., Thanei M., Erni B., Lecourt A.C., Branco L., André R., Roux-Lombard P., Koenig K.F., Huynh-Do U., Ribi C. et al., 2019/05/01. Rheumatology, 58 (5) pp. 908-913. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_178CB13DB61C]
Detection of antisense protein (ASP) RNA transcripts in individuals infected with human immunodeficiency virus type 1 (HIV-1).
Mancarella A., Procopio F.A., Achsel T., De Crignis E., Foley B.T., Corradin G., Bagni C., Pantaleo G., Graziosi C., 2019/05. The Journal of general virology, 100 (5) pp. 863-876. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_4178D396A6C4]
 
Gene therapy for Wiskott-Aldrich syndrome: here to stay.
Candotti F., 2019/05. The Lancet. Haematology, 6 (5) pp. e230-e231. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_21FD1FD5EF0A]
 
Multi-arm, multi-stage randomised controlled trials for evaluating therapeutic HIV cure interventions.
Moore C.L., Stöhr W., Crook A.M., Richert L., Leliévre J.D., Pantaleo G., García F., Vella S., Lévy Y., Thiébaut R. et al., 2019/05. The lancet. HIV, 6 (5) pp. e334-e340. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2A5E5DD64601]
Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research (EUSTAR) cohort
Wu Wanlong, Jordan Suzana, Graf Nicole, de Oliveira Pena Janethe, Curram John, Allanore Yannick, Matucci-Cerinic Marco, Pope Janet E, Denton Christopher P, Khanna Dinesh et al., 2019/05. Annals of the Rheumatic Diseases, 78 (5) pp. 648-656.
[URN][DOI][WoS][Pmid][serval:BIB_3BA3362D678D]
Davantage de silence.
Seebach J., Spertini F., 2019/04/03. Revue medicale suisse, 15 (645) pp. 703-704. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_9E7BA84A8543]
De la vasculite cutanée isolée aux atteintes systémiques : l’approche diagnostique d’un purpura chez l’adulte [From isolated cutaneous vasculitis to systemic disease : a diagnostic approach to purpura in the adult patient]
Horisberger A., Ghosn J., Di Lucca J., Comte D., 2019/04/03. Revue medicale suisse, 15 (645) pp. 713-718. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_E2CDB3FC1A4D]
 
L’allergie au poisson [Allergy to fish]
Mahdi Aljedani R., Ribi C., 2019/04/03. Revue medicale suisse, 15 (645) pp. 706-709. Peer-reviewed.
[Pmid][serval:BIB_ABBDA2836CF0]
 
Manifestations auto-immunes au cours de l’infection chronique par le virus de l’immunodéficience humaine (VIH) [Autoimmune disorders during chronic human immunodeficiency virus (HIV) infection]
Filippidis P., Comte D., 2019/04/03. Revue medicale suisse, 15 (645) pp. 723-731. Peer-reviewed.
[Pmid][serval:BIB_D554AA9F9787]
 
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting.
Julg B., Dee L., Ananworanich J., Barouch D.H., Bar K., Caskey M., Colby D.J., Dawson L., Dong K.L., Dubé K. et al., 2019/04. The lancet. HIV, 6 (4) pp. e259-e268. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_D9BACB56B9AE]
The Fatigue Assessment Scale as a simple and reliable tool in systemic lupus erythematosus: a cross-sectional study.
Horisberger A., Courvoisier D., Ribi C., 2019/03/25. Arthritis research & therapy, 21 (1) p. 80. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_581C1DBAA28B]
Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus.
Marcandalli J., Fiala B., Ols S., Perotti M., de van der Schueren W., Snijder J., Hodge E., Benhaim M., Ravichandran R., Carter L. et al., 2019/03/07. Cell, 176 (6) pp. 1420-1431.e17. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_9448E40DDE5A]
HIV Infection Functionally Impairs Mycobacterium tuberculosis-Specific CD4 and CD8 T-Cell Responses.
Amelio P., Portevin D., Hella J., Reither K., Kamwela L., Lweno O., Tumbo A., Geoffrey L., Ohmiti K., Ding S. et al., 2019/03/01. Journal of virology, 93 (5). Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_0A2A8987D545]
Treatment of chronic non-infectious uveitis and scleritis.
Rossi D.C., Ribi C., Guex-Crosier Y., 2019/02/25. Swiss medical weekly, 149 pp. w20025. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_CEF6ECB55ECE]
PD-1 blockade potentiates HIV latency reversal ex vivo in CD4<sup>+</sup> T cells from ART-suppressed individuals.
Fromentin R., DaFonseca S., Costiniuk C.T., El-Far M., Procopio F.A., Hecht F.M., Hoh R., Deeks S.G., Hazuda D.J., Lewin S.R. et al., 2019/02/18. Nature communications, 10 (1) p. 814. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3CB01C4A8D69]
 
Importance of routine viral load monitoring: higher levels of resistance at ART failure in Uganda and Lesotho compared with Switzerland.
Bachmann N., von Braun A., Labhardt N.D., Kadelka C., Günthard H.F., Sekaggya-Wiltshire C., Castelnuovo B., Kambugu A., Lejone T.I., Böni J. et al., 2019/02/01. The Journal of antimicrobial chemotherapy, 74 (2) pp. 468-472. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_736FEAF554BB]
 
Priming with a Potent HIV-1 DNA Vaccine Frames the Quality of Immune Responses prior to a Poxvirus and Protein Boost.
Asbach B., Kibler K.V., Köstler J., Perdiguero B., Yates N.L., Stanfield-Oakley S., Tomaras G.D., Kao S.F., Foulds K.E., Roederer M. et al., 2019/02/01. Journal of virology, 93 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_011979DE2022]
 
Replication-Competent NYVAC-KC Yields Improved Immunogenicity to HIV-1 Antigens in Rhesus Macaques Compared to Nonreplicating NYVAC.
Kibler K.V., Asbach B., Perdiguero B., García-Arriaza J., Yates N.L., Parks R., Stanfield-Oakley S., Ferrari G., Montefiori D.C., Tomaras G.D. et al., 2019/02/01. Journal of virology, 93 (3). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_C7AB149CAD1E]
 
The Candidate Blood-stage Malaria Vaccine P27A Induces a Robust Humoral Response in a Fast Track to the Field Phase 1 Trial in Exposed and Nonexposed Volunteers.
Steiner-Monard V., Kamaka K., Karoui O., Roethlisberger S., Audran R., Daubenberger C., Fayet-Mello A., Erdmann-Voisin A., Felger I., Geiger K. et al., 2019/01/18. Clinical infectious diseases, 68 (3) pp. 466-474. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_31F5C60B7749]
Allergologie-immunologie: Effets secondaires des immunothérapies du cancer : du travail pour l’immunologue clinique [Side effects of cancer immunotherapies : important role for the clinical immunologist]
Obeid M., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 17-19. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_C148880B688D]
Allergologie-immunologie: Facteurs d’échec du traitement de l’asthme et nouveautés thérapeutiques [Risk of treatment failure and therapeutic novelties in asthma]
Horisberger A., Mahdi Aljedani R., Spertini F., Ribi C., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 23-26. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_0C52767F8451]
Allergologie-immunologie: Où en est-on avec l’immunothérapie orale dans l’allergie alimentaire ? [Where are we with oral immunotherapy for food allergy ?]
Borgeat Kaeser A., Moi L., Spertini F., 2019/01/09. Revue medicale suisse, 15 (N° 632-633) pp. 20-22. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_184FC25FB913]
A Rare Case of Diffuse Polyarthritis in the Context of an Epididymoorchitis due to Mumps Infection
Van Singer M., Felix N., Perreau M., Lebowitz D., Comte D., 2019. Rheumatology: Current Research, 09 (02). Peer-reviewed.
[URN][DOI][serval:BIB_02444DED55E6]
Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site.
Csorba K., Schirmbeck L.A., Tuncer E., Ribi C., Roux-Lombard P., Chizzolini C., Huynh-Do U., Vanhecke D., Trendelenburg M., 2019. Frontiers in immunology, 10 p. 2619. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_6F89C6AE8267]
Comparative analysis and generation of a robust HIV-1 DNA quantification assay.
Thomas J., Ruggiero A., Procopio F.A., Pantaleo G., Paxton W.A., Pollakis G., 2019/01. Journal of virological methods, 263 pp. 24-31. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_62022265AD93]
 
Heterologous Combination of VSV-GP and NYVAC Vectors Expressing HIV-1 Trimeric gp145 Env as Vaccination Strategy to Induce Balanced B and T Cell Immune Responses.
Perdiguero B., Gómez C.E., García-Arriaza J., Sánchez-Corzo C., Sorzano CÓS, Wilmschen S., von Laer D., Asbach B., Schmalzl C., Peterhoff D. et al., 2019. Frontiers in immunology, 10 p. 2941. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_61B1B7E651FD]
 
Human gut microbiota is associated with HIV-reactive immunoglobulin at baseline and following HIV vaccination.
Cram J.A., Fiore-Gartland A.J., Srinivasan S., Karuna S., Pantaleo G., Tomaras G.D., Fredricks D.N., Kublin J.G., 2019. PloS one, 14 (12) pp. e0225622. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_F7483D5519F1]
 
Monitoring Antigen Processing for MHC Presentation via Macroautophagy
Gannage M., da Silva R. B., Munz C., 2019. Methods Mol Biol, 1988 pp. 357-373.
[DOI][Pmid][serval:BIB_1BCF16B5A834]
New therapeutic perspectives to manage refractory immune checkpoint-related toxicities.
Martins F., Sykiotis G.P., Maillard M., Fraga M., Ribi C., Kuntzer T., Michielin O., Peters S., Coukos G., Spertini F. et al., 2019/01. The Lancet. Oncology, 20 (1) pp. e54-e64. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_42DB9145A8A7]
 
Novel Nanofluidic IgE Assay versus a Reference Method: A Real-World Comparison.
Roethlisberger S., Karoui O., Mapelli D., Audran R., Aubert V., Girard L.D., Rebeaud F., Leimgruber A., Buss G., Duc J. et al., 2019. International archives of allergy and immunology, 180 (1) pp. 28-36. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_B72703B3645C]
Re-boost immunizations with the peptide-based therapeutic HIV vaccine, Vacc-4x, restores geometric mean viral load set-point during treatment interruption.
Rockstroh J.K., Asmuth D., Pantaleo G., Clotet B., Podzamczer D., van Lunzen J., Arastéh K., Mitsuyasu R., Peters B., Silvia N. et al., 2019. PloS one, 14 (1) pp. e0210965. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_70A55586092A]
 
Signaling Lymphocytic Activation Molecule Family Member 1 Engagement Inhibits T Cell-B Cell Interaction and Diminishes Interleukin-6 Production and Plasmablast Differentiation in Systemic Lupus Erythematosus.
Karampetsou M.P., Comte D., Suárez-Fueyo A., Katsuyama E., Yoshida N., Kono M., Kyttaris V.C., Tsokos G.C., 2019/01. Arthritis & rheumatology, 71 (1) pp. 99-108. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_2CF54215DED7]
2018
A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy.
Horisberger A., La Rosa S., Zurcher J.P., Zimmermann S., Spertini F., Coukos G., Obeid M., 2018/12/27. Journal for immunotherapy of cancer, 6 (1) p. 156. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_BD7EE077DFE6]
 
Eosinophilic esophagitis: latest insights from diagnosis to therapy.
Schoepfer A., Blanchard C., Dawson H., Lucendo A., Mauro A., Ribi C., Safroneeva E., Savarino E.V., Penagini R., 2018/12. Annals of the New York Academy of Sciences, 1434 (1) pp. 84-93. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_0934BFC8EBCD]
 
Natural Secretory Immunoglobulins Promote Enteric Viral Infections.
Turula H., Bragazzi Cunha J., Mainou B.A., Ramakrishnan S.K., Wilke C.A., Gonzalez-Hernandez M.B., Pry A., Fava J., Bassis C.M., Edelman J. et al., 2018/12/01. Journal of virology, 92 (23). Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_17273F3FE605]
Walking performances and muscle oxygen desaturation are increased after supervised exercise training in Takayasu arteritis: a case report and a review of the literature.
Lanzi S., Calanca L., Borgeat Kaeser A., Mazzolai L., 2018/12. European heart journal. Case reports, 2 (4) pp. yty123. Peer-reviewed.
[URN][DOI][Pmid][serval:BIB_AC469B29231C]
 
Quantifying the drivers of HIV transmission and prevention in men who have sex with men: a population model-based analysis in Switzerland.
Kusejko K., Marzel A., Hampel B., Bachmann N., Nguyen H., Fehr J., Braun D.L., Battegay M., Bernasconi E., Calmy A. et al., 2018/11. HIV medicine, 19 (10) pp. 688-697. Peer-reviewed.
[DOI][WoS][Pmid][serval:BIB_3BDC797AB74F]
Prospective evaluation of the capillaroscopic skin ulcer risk index in systemic sclerosis patients in clinical practice: a longitudinal, multicentre study.
Walker U.A., Jaeger V.K., Bruppacher K.M., Dobrota R., Arlettaz L., Banyai M., Beron J., Chizzolini C., Groechenig E., Mueller R.B. et al., 2018/10/25. Arthritis research & therapy, 20 (1) p. 239. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3B4A790361F0]
A severe case of neuro-Sjögren's syndrome induced by pembrolizumab.
Ghosn J., Vicino A., Michielin O., Coukos G., Kuntzer T., Obeid M., 2018/10/22. Journal for immunotherapy of cancer, 6 (1) p. 110. Peer-reviewed.
[URN][DOI][WoS][Pmid][serval:BIB_3E8CC11BAFBA]
Partagez:
Unicentre - CH-1015 Lausanne
Suisse
Tél. +41 21 692 11 11
Canton de Vaud
Swiss University